Table 6.
Method | Target | Major side effects | Selectivity |
Steroids | Lymphocytes/RES | Osteoporosis, diabetes, psychosis, infection, obesity | + |
Azathioprine | Lymphocytes | Marrow suppression, hepatopathy | ++ |
Polyclonal antithymocyte globulin | T lymphocytes | Infection, malignancies | ++ |
Monoclonal CD3 antibodies | CD3+ T lymphocytes | Infection, malignancies | +++ |
Mycophenolate | De novo purine synthesis in lymphocytes | Gastrointestinal | ++++ |
Cyclosporine | IL2 inhibition in T lymphocytes | Nephropathy | ++++ |
Tacrolimus | IL2 inhibition in T lymphocytes | Nephropathy | ++++ |
Daclizumab | IL2 receptor antibodies | None | ++++ |
RES, reticuloendothelial system.